Chlamydial vaccine development

Journal of Medical Microbiology

Volumn 52, Issue 7, 2003, Pages 537-540

  Longbottom, David ^a  

^a MOREDUN RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; CHLAMYDIA VACCINE; OUTER MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; DRUG DELIVERY SYSTEM; EDITORIAL; HUMAN; IMMUNITY; PRIORITY JOURNAL; VACCINATION;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CHLAMYDIA; CHLAMYDIA INFECTIONS; HUMANS; VACCINES, DNA; VACCINES, SYNTHETIC;

EID: 0037765135     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.05093-0     Document Type: Editorial

References (39)

1. Antex Biologics (2003). Antex files Chlamydia investigational new drug application with FDA. STD vaccine clinical trial. Press release, 3 February 2003. http://www.antexbiologics.com/news_pr/pr030203.phtm
2. + T cells. Immunology 77, 284-288.
3. de la Maza, M. A. & de la Maza, L. M. (1995). A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. Vaccine 13, 119-127.
4. Entrican, G., Buxton, D. & Longbottom, D. (2001). Chlamydial infection in sheep: immune control versus fetal pathology. J R Soc Med 94, 273-277.
5. + T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Proc Natl Acad Sci U S A 98, 1160-1165.
6. Gentschev, I., Dietrich, G., Spreng, S., Pilgrim, S., Stritzker, J., Kolb-Maurer, A. & Goebel, W. (2002). Delivery of protein antigens and DNA by attenuated intracellular bacteria. Int J Med Microbiol 291, 577-582.
7. Hayes, L. J., Conlan, J. W., Everson, J. S., Ward, M. E. & Clarke, I. N. (1991). Chlamydia trachomatis major outer membrane protein epitopes expressed as fusions with LamB in an attenuated aroA strain of Salmonella typhimurium; their application as potential immunogens. J Gen Microbiol 137, 1557-1564.
8. Henderson, I. R. & Lam, A. C. (2001). Polymorphic proteins of Chlamydia spp. autotransporters beyond the Proteobacteria. Trends Microbiol 9, 573-578.
9. Herring, A. J., Jones, G. E., Dunbar, S. M., Nettleton, P. F., Fitzgerald, T. A., Anderson, I. E., Chapman, S. N. & Wilson, T. M. A. (1998). Recombinant vaccines against Chlamydia psittaci - an overview of results using bacterial expression and a new approach using a plant virus 'overcoat' system. In Proceedings of the Ninth International Symposium on Human Chlamydial Infection, pp. 434-437. Edited by R. S. Stephens, G. I. Byrne, G. Christiansen & 7 others. San Francisco: International Chlamydia Symposium.
10. Hsia, R. C., Pannekoek, Y., Ingerowski, E. & Bavoil, P. M. (1997). Type III secretion genes identify a putative virulence locus of Chlamydia. Mol Microbiol 25, 351-359.
11. Igietseme, J. U. (2002). Functional immunobiology of Chlamydia: vaccine perspective. In Proceedings of the Tenth International Symposium on Human Chlamydial Infections, pp. 223-232. Edited by J. Schachter, G. Christiansen, I. N. Clarke & 11 others. San Francisco: International Chlamydia Symposium.
12. Lampe, M. F., Ballweber, L. M. & Stamm, W. E. (1998a). Cloning and sequence analysis of a putative cytolysin from Chlamydia trachomatis. In Proceedings of the Ninth International Symposium on Human Chlamydial Infection, pp. 555-558. Edited by R. S. Stephens, G. I. Byrne, G. Christiansen & 7 others. San Francisco: International Chlamydia Symposium.
13. Lampe, M. F., Wilson, C. B., Bevan, M. J. & Starnbach, M. N. (1998b). Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection. Infect Immun 66, 5457-5461.
14. Longbottom, D. & Coulter, L. J. (2003). Animal chlamydioses and zoonotic implications. J Comp Pathol 128, 217-244.
15. Longbottom, D., Findlay, J., Vretou, E. & Dunbar, S. M. (1998a). Immunoelectron microscopic localisation of the OMP90 family on the outer membrane surface of Chlamydia psittaci. FEMS Microbiol Lett 164, 111-117.
16. Longbottom, D., Russell, M., Dunbar, S. M., Jones, G. E. & Herring, A. J. (1998b). Molecular cloning and characterization of the genes coding for the highly immunogenic cluster of 90-kilodalton envelope proteins from the Chlamydia psittaci subtype that causes abortion in sheep. Infect Immun 66, 1317-1324.
17. Lu, H. & Zhong, G. M. (1999). Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection. Infect Immun 67, 1763-1769.
18. Moore, T., Ananaba, G. A., Bolier, J., Bowers, S., Belay, T., Eko, F. O. & Igietseme, J. U. (2002). Fc receptor regulation of protective immunity against Chlamydia trachomatis. Immunology 105, 213-221.
19. Murdin, A. D., Su, H., Manning, D. S., Klein, M. H., Parnell, M. J. & Caldwell, H. D. (1993). A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic. Infect Immun 61, 4406-4414.
20. Murdin, A. D., Dunn, P., Sodoyer, R., Wang, J., Caterini, J., Brunham, R. C., Aujame, L. & Oomen, R. (2000). Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection. J Infect Dis 181 (Suppl. 3), S544-S551.
21. Pal, S., Barnhart, K. M., Wei, Q., Abai, A. M., Peterson, E. M. & de la Maza, L. M. (1999). Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge. Vaccine 17, 459-465.
22. Rank, R. G. (1999). Models of immunity. In Chlamydia: Intracellular Biology, Pathogenesis and Immunity, pp. 239-295. Edited by R. S. Stephens. Washington, DC: American Society for Microbiology.
23. Rank, R. G. & Batteiger, B. E. (1989). Protective role of serum antibody in immunity to chlamydial genital infection. Infect Immun 57, 299-301.
24. Rank, R. G., White, H. J. & Barron, A. L. (1979). Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun 26, 573-579.
25. Read, T. D., Brunham, R. C., Shen, C. & 22 other authors (2000). Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res 28, 1397-1406.
26. Rockey, D. D., Lenart, J. & Stephens, R. S. (2000). Genome sequencing and our understanding of chlamydiae. Infect Immun 68, 5473-5479.
27. Saikku, P. (1998). Chlamydia pneumoniae - clinical spectrum. In Proceedings of the Ninth International Symposium on HumanChlamydial Infection, pp. 145-154. Edited by R. S. Stephens, G. I. Byrne, G. Christiansen & 7 others. San Francisco: International Chlamydia Symposium.
28. Schachter, J. (1988). Overview of human diseases. In Microbiology of Chlamydia, pp. 153-165. Edited by A. L. Barron. Boca Raton, FL: CRC Press.
29. + type 2 rather than type 1 immune response that is not protective. Infect Immun 70, 1097-1105.
30. Stagg, A. J. (1998). Vaccines against Chlamydia: approaches and progress. Mol Med Today 4, 166-173.
31. Stephens, R. S., Kalman, S., Lammel, C. & 9 other authors (1998). Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282, 754-759.
32. Storz, J. (1988). Overview of animal diseases induced by chlamydial infections. In Microbiology of Chlamydia, pp. 167-192. Edited by A. L. Barron. Boca Raton, FL: CRC Press.
33. Stuart, E. S., Tirrell, S. M. & MacDonald, A. B. (1987). Characterization of an antigen secreted by Chlamydia-infected cell culture. Immunology 61, 527-533.
34. Su, H., Feilzer, K., Caldwell, H. D. & Morrison, R. P. (1997). Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect Immun 65, 1993-1999.
35. Su, H., Messer, R., Whitmire, W., Fischer, E., Portis, J. C. & Caldwell, H. D. (1998). Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable chlamydiae. J Exp Med 188, 809-818.
36. Turner, M. S. & Giffard, P. M. (1999). Expression of Chlamydia psittaci- and human immunodeficiency virus-derived antigens on the cell surface of Lactobacillus fermentum BR11 as fusions to BspA. Infect Immun 67, 5486-5489.
37. Vanrompay, D., Cox, E., Vandenbussche, F., Volckaert, G. & Goddeeris, B. (1999). Protection of turkeys against Chlamydia psittaci challenge by gene gun-based DNA immunizations. Vaccine 17, 2628-2635.
38. Ward, M. E. (1999). Mechanisms of disease. In Chlamydia: Intracellular Biology, Pathogenesis and Immunity, pp. 171-210. Edited by R. S. Stephens. Washington, DC: American Society for Microbiology.
39. Zhang, D., Yang, X., Berry, J., Shen, C., McClarty, G. & Brunham, R. C. (1997). DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. J Infect Dis 176, 1035-1040.